IRF4 and mature T-cell and NK-cell non-Hodgkin lymphoma: MYC expression was higher in patients with IRF4 gain than in those without (Fig. S20), consistent with previous reports that IRF4 overexpression caused increased MYC promoter activity in a PTCL cell line [35].